SAN FRANCISCO — The use of high-dose oral vitamin therapy failed to reduce the risk of cardiovascular events in the Trial to Assess Chelation Therapy (TACT), a 2x2 factorial-design, randomized, double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results